HSA Singapore Issues Updated Guidance on Medical Device…
On 5 November 2025, the Health Sciences Authority (HSA) of Singapore released new guidance documents outlining regulatory requirements for m…
Read more
Singapore’s HSA Issues Updated Health Supplement Regu…
On 29 October 2025, the Health Sciences Authority (HSA) of Singapore published updated guidelines governing prohibited and restricted ingred…
Read more
Indonesia BPOM Revises Drug Registration Rules to Strea…
Published on August 19, 2025, by the Indonesian National Agency of Drug and Food Control (BPOM), Regulation No. 23 of 2025 introduces major…
Read more
RegASK sponsors Pharma Japan 2025
RegASK is proud to participate in Pharma Japan 2025, Japan’s premier executive conference for the pharmaceutical industry, bringing togeth…
Read more
RegASK sponsors DIA Singapore Annual Meeting 2025
Proud Silver Sponsor | Booth 7 RegASK is proud to be a Silver Sponsor of the DIA Singapore Annual Meeting 2025, one of Asia’s leading conf…
Read more
FSANZ Notifies Draft Code Changes to Infant Formula Sta…
FSANZ Proposes New Standards for Infant Formula Products in Australia Food Standards Australia New Zealand (FSANZ) has released draft change…
Read more
CDE (China) Publishes Guideline for Biologics Registrat…
On February 9, 2025, the Center for Drug Evaluation (CDE) announced the release of the “Guideline for Acceptance Review of Biological …
Read more
Vietnam Strengthens Oversight of Cosmetic Trading on So…
On January 13, 2025, the Drug Administration of Vietnam (DAV), under the Ministry of Health, issued Official Dispatch No. 119/QLD-MP, focusi…
Read more
MPI (New Zealand) Consults on Proposed Amendments to Im…
On 13 January 2025, the New Zealand Ministry for Primary Industries (MPI) announced a public consultation on proposed changes to the Import …
Read more
Ministry of Environment (South Korea) Amends Guidelines…
On January 8, 2024, the Ministry of Environment of South Korea announced a public consultation on the draft amendment titled “Standard…
Read more